ArticleJul 21, 2025Pathophysiology of Bullous PemphigoidIn bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out moreLearn more
ArticleJul 16, 2025Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity Learn more